Modeling & Simulation Workshop – China Live Events Modeling & Simulation Workshop – China Danielle PillsburyJuly 28, 2026
Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate Publication Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate See how QSP modeling guided the design of a reversible antibody switch that unmasks IL-12…CertaraJuly 24, 2026
Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification Poster Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification See how Simcyp Simulator V20–V24 DDI predictions were shown equivalent to the EMA-qualified V19 using…CertaraJuly 24, 2026
Important drug development questions that model-based meta-analysis answers Blog Important drug development questions that model-based meta-analysis answers Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…Matt Zierhut, PhD MBAJuly 23, 2026
Phoenix Pharmacometrics Day – Korea Live Events Phoenix Pharmacometrics Day – Korea CertaraJuly 23, 2026
Unlock the Power of SEND Data: From FDA Compliance to Global Regulatory Readiness for Preclinical Data [Korean Webinar with Biotoxtech] On-Demand Webinar Unlock the Power of SEND Data: From FDA Compliance to Global Regulatory Readiness for Preclinical Data [Korean Webinar with Biotoxtech] CertaraJuly 22, 2026
A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans Poster A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…CertaraJuly 20, 2026
Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data Publication Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data QSP modeling reveals patient-specific factors driving CAR T-cell response and relapse in multiple myeloma, with…CertaraJuly 20, 2026